Package 70710-1397-7

{"route": ["ORAL"], "spl_id": "8f8b3109-d174-4138-b14f-f956a4578ca9", "openfda": {"upc": ["0370710139636", "0370710139735"], "unii": ["4U07F515LG"], "rxcui": ["825421", "825427", "884617", "1245001"], "spl_set_id": ["1cfdd1fa-d687-41f9-a160-9491f0beac1e"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (70710-1397-3)", "package_ndc": "70710-1397-3", "marketing_start_date": "20260114"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (70710-1397-7)", "package_ndc": "70710-1397-7", "marketing_start_date": "20260114"}], "brand_name": "ELTROMBOPAG", "product_id": "70710-1397_8f8b3109-d174-4138-b14f-f956a4578ca9", "dosage_form": "TABLET", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Increased Megakaryocyte Maturation [PE]", "Increased Platelet Production [PE]", "Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]", "Thrombopoietin Receptor Agonist [EPC]", "Thrombopoietin Receptor Agonists [MoA]", "UGT1A1 Inhibitors [MoA]", "UGT1A3 Inhibitors [MoA]", "UGT1A4 Inhibitors [MoA]", "UGT1A6 Inhibitors [MoA]", "UGT1A9 Inhibitors [MoA]", "UGT2B15 Inhibitors [MoA]", "UGT2B7 Inhibitors [MoA]"], "product_ndc": "70710-1397", "generic_name": "eltrombopag", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ELTROMBOPAG", "active_ingredients": [{"name": "ELTROMBOPAG OLAMINE", "strength": "50 mg/1"}], "application_number": "ANDA216281", "marketing_category": "ANDA", "marketing_start_date": "20260114", "listing_expiration_date": "20271231"}